Vaughan Nelson Investment Management L.P. Purchases 458,620 Shares of Bath & Body Works, Inc. $BBWI

Vaughan Nelson Investment Management L.P. boosted its holdings in Bath & Body Works, Inc. (NYSE:BBWI) by 27.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 2,132,245 shares of the company’s stock after purchasing an additional 458,620 shares during the quarter. Vaughan Nelson Investment Management L.P.’s holdings in Bath & Body Works were worth $42,815,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of BBWI. Retirement Systems of Alabama lifted its stake in shares of Bath & Body Works by 7.7% in the fourth quarter. Retirement Systems of Alabama now owns 832,016 shares of the company’s stock valued at $16,707,000 after buying an additional 59,692 shares in the last quarter. Wedge Capital Management L L P NC increased its position in shares of Bath & Body Works by 49.9% during the fourth quarter. Wedge Capital Management L L P NC now owns 214,362 shares of the company’s stock worth $4,304,000 after acquiring an additional 71,349 shares in the last quarter. Pallas Capital Advisors LLC raised its holdings in shares of Bath & Body Works by 108.3% in the 4th quarter. Pallas Capital Advisors LLC now owns 43,519 shares of the company’s stock worth $874,000 after acquiring an additional 22,623 shares during the last quarter. Quantum Financial Advisors LLC acquired a new stake in shares of Bath & Body Works in the 4th quarter worth about $375,000. Finally, SG Americas Securities LLC lifted its position in Bath & Body Works by 725.3% in the 4th quarter. SG Americas Securities LLC now owns 466,338 shares of the company’s stock valued at $9,364,000 after acquiring an additional 409,831 shares in the last quarter. Institutional investors own 95.14% of the company’s stock.

Bath & Body Works Stock Performance

NYSE:BBWI opened at $18.73 on Tuesday. Bath & Body Works, Inc. has a 52 week low of $14.27 and a 52 week high of $34.66. The firm has a 50-day moving average price of $21.56 and a two-hundred day moving average price of $22.24. The firm has a market cap of $3.77 billion, a price-to-earnings ratio of 5.95, a price-to-earnings-growth ratio of 1.68 and a beta of 1.48.

Bath & Body Works (NYSE:BBWI) last announced its earnings results on Wednesday, March 4th. The company reported $2.05 earnings per share for the quarter, topping analysts’ consensus estimates of $1.77 by $0.28. The firm had revenue of $2.72 billion for the quarter, compared to the consensus estimate of $2.59 billion. Bath & Body Works had a negative return on equity of 45.60% and a net margin of 8.90%.The company’s revenue was down 2.3% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.09 EPS. Bath & Body Works has set its Q1 2026 guidance at 0.240-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. As a group, sell-side analysts forecast that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.

Bath & Body Works Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 6th. Shareholders of record on Friday, February 20th were paid a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 4.3%. The ex-dividend date was Friday, February 20th. Bath & Body Works’s dividend payout ratio is 25.40%.

Analyst Ratings Changes

A number of brokerages have commented on BBWI. Guggenheim started coverage on Bath & Body Works in a report on Tuesday, December 9th. They set a “neutral” rating for the company. Citigroup lowered Bath & Body Works from a “buy” rating to a “neutral” rating and raised their target price for the company from $21.00 to $25.00 in a report on Tuesday, February 17th. Robert W. Baird set a $20.00 price target on Bath & Body Works in a report on Wednesday, December 17th. Jefferies Financial Group initiated coverage on Bath & Body Works in a research report on Wednesday, January 14th. They issued a “hold” rating and a $24.00 price target for the company. Finally, Telsey Advisory Group raised their price objective on Bath & Body Works from $23.00 to $25.00 and gave the company a “market perform” rating in a research note on Thursday, March 5th. Three investment analysts have rated the stock with a Buy rating and fourteen have given a Hold rating to the company’s stock. Based on data from MarketBeat, Bath & Body Works presently has a consensus rating of “Hold” and an average target price of $24.00.

About Bath & Body Works

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.